We are a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments for hearing and balance disorders, one of the largest areas of unmet need in medicine. We aim to restore and improve hearing and balance through the restoration and regeneration of functional hair cells and non-sensory support cells within the inner ear. We have built […]

We are a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to employ the body’s own T cells to generate a specific, potent and durable immune response that mimics natural biology. Our mission is to create therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. Currently, we have two […]

Talis aims to transform diagnostic testing by developing and commercializing innovative products that are designed to enable accurate, reliable, low cost and rapid molecular testing for infectious diseases and other conditions at the point-of-care. While timely diagnosis of infectious diseases is critically important to enable effective treatment, testing is primarily performed in centralized laboratories, which require samples […]

Note: Steve Young, the retired San Francisco ’49ers star who is a co-founder and the president of HGGC, a Palo Alto-based middle-market private equity firm, will serve as a director of this new blank-check company.  Pathfinder Acquisition, incorporated in 2020 in the Cayman Islands, is backed by HGGC affiliates and Industry Ventures, a venture capital […]

We intend to focus on industries that complement our management team’s background, and to capitalize on the ability of our management team to identify and acquire a technology business focusing on verticals of the real estate industry, as well as the adjacent industries that collectively make up the human-made environment that provides the setting for […]

COVA Acquisition Corp. is a newly organized blank check company incorporated as a Cayman Islands exempt company on Dec. 11, 2020. We currently intend to focus our efforts on identifying high growth technology and tech-enabled businesses in Southeast Asia in the consumer internet, ecommerce, and software industries. We will focus on targets within these industries that are […]

We are a global medical device company focused on developing and commercializing clinically differentiated, cost efficient and minimally invasive treatments that engage and enhance the body’s natural healing process. We believe our non-invasive medical device and biologic products play a critical role in supporting the body’s own healing mechanisms to heal or eliminate the pain caused by […]

AFC Gamma, Inc. is a commercial real estate finance company founded in July 2020 by a veteran team of investment professionals. We originate, structure, underwrite and manage senior secured loans and other types of loans for established companies operating in the cannabis industry in states that have legalized medicinal and/or adult use cannabis. As states […]

We are a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based cancer immunotherapies. Our platform is designed to generate therapeutic antibody candidates with unique functional epitopes and species cross-reactivity as highlighted by our immunotherapy pipeline.  (Note: Adagene priced its IPO on Feb. 8, 2021, at $19 – the top […]

We are one of the few (if not the first) blank check companies to obtain Pending B Corp status. To become a Pending B Corp, we, among other things, incorporated as a public benefit corporation. The B Corp framework is highly aligned with benchmarking progress toward achieving the United Nations’ Sustainable Development Goals (the “UN SDGs”) […]